Executives from seven pharmaceutical giants endure grillings but also push back Tuesday on Capitol Hill, as they testify before the Senate Finance Committee about rising drug prices.
Executives from seven pharmaceutical giants endured grillings but also pushed back, as they testified before the Senate Finance Committee on Tuesday about rising drug prices. While Iowa Republican Sen. Chuck Grassley, the committee’s chairman, said the hearing was “not about scapegoating,” Oregon Democratic Sen. Ron Wyden said prices “are astronomically high because that’s where pharmaceutical companies and their investors want them.
28% AZN, -0.30% BMY, -0.80% MRK, +0.80% PFE, +0.22% SNY, +1.59% SAN, +0.00% sent their chief executives to Capitol Hill on Tuesday, while Johnson & Johnson JNJ, +0.13% dispatched an executive vice president to testify. The seven drug makers mostly traded higher on Tuesday, while the S&P 500 SPX, +0.12% was recently flat to slightly down.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pharmaceutical executives on Capitol Hill answer questions on rising drug costsThe top executives from seven major drugmakers told a Senate committee Tuesday that their industry isn’t solely to blame for historically high drug prices, setting up a clash with lawmakers who insist the companies are gaming a broken system. The testimony from several drug industry CEOs is the first
Read more »
‘It’s finally pharma’s turn’: Drug CEOs face Capitol Hill reckoningSeven drugmakers will be grilled over high prices at a hearing this week, in what could be a watershed moment for the industry.
Read more »
Pharmaceutical Industry CEOs Face Senate Hearing on Drug PricesExecutives for some of the biggest drug companies will visit Capitol Hill on Tuesday to face tough questions in a Senate hearing on the rising cost of medicines.
Read more »
These are the top executives in EuropeInstitutional Investor ranked the continent's best CEOs, CFOs, and investor relations professionals across 31 industries.
Read more »
Live Analysis: Drug-Company CEOs Take the Hot Seat Before CongressRising drug prices will be in the spotlight as pharmaceutical industry executives testify before the Senate Finance Committee, where lawmakers are expected to ask executives from firms such as Merck and Pfizer about their pricing practices and other issues.
Read more »
How CEOs can game the system to make money when the company's stock fallsCEOs can make hundreds of thousands of additional dollars by sending out a press release with negative news just as the window opens to purchase stock.
Read more »
The 25 CEOs whose pay is most wildly out of sync with their company's performanceCheck out which 25 CEOs earn a salary that's higher than expected given shareholder return, according to a report from As You Sow.
Read more »